Literature DB >> 9402580

Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans.

R S Clark1, J A Carcillo, P M Kochanek, W D Obrist, E K Jackson, Z Mi, S R Wisneiwski, M J Bell, D W Marion.   

Abstract

OBJECTIVE: Uncoupling of cerebral blood flow (CBF) and oxidative metabolism is observed after severe head injury in comatose patients; however, the mechanism(s) involved remain undefined. Adenosine can produce cerebral vasodilation and reduce neuronal activity and is a possible mediator of uncoupling. We hypothesized that cerebrospinal fluid (CSF) adenosine concentrations would be increased during uncoupling of CBF and oxidative metabolism, defined as a narrow arterio-jugular venous oxygen difference [D(a-v)O2 4 vol%] after head injury.
METHODS: Adenosine concentrations were measured using fluorescent-based high-pressure liquid chromatography in 67 CSF samples obtained from 13 comatose (Glasgow Coma Scale score 7) adult patients who sustained a severe closed head injury. At the time each sample was obtained, CBF was measured by the xenon-133 method, and blood samples were obtained for determination of D(a-v)O2.
RESULTS: CSF adenosine concentration was negatively associated with D(a-v)O2 (P < 0.05, generalized multivariate linear regression model). In addition, CSF adenosine concentration was increased when D(a-v)O2 was 4 versus > 4 vol% (38.5 [3.2-306.3] versus 14.0 [2.7-795.5] nmol/L, respectively, median [range]; P < 0.025) and in patients who died versus survivors (40.1 [6.9-306.3] versus 12.9 [2.7-795.5] nmol/L, respectively, median [range]; P < 0.001).
CONCLUSION: The association between increased CSF adenosine concentration and a reduction in global cross-brain extraction of oxygen supports a regulatory role for adenosine in the complex balance between CBF and oxidative and nonoxidative metabolism severe head injury in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402580     DOI: 10.1097/00006123-199712000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

Review 1.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 2.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

3.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

Review 4.  Intraoperative Targeted Temperature Management in Acute Brain and Spinal Cord Injury.

Authors:  Jacqueline Kraft; Anna Karpenko; Fred Rincon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 5.  Adenosine dysfunction in epilepsy.

Authors:  Detlev Boison
Journal:  Glia       Date:  2011-12-22       Impact factor: 7.452

6.  Early temporal changes in ecto-nucleotidase activity after cortical stab injury in rat.

Authors:  Nadezda Nedeljkovic; Ivana Bjelobaba; Irena Lavrnja; Danijela Stojkov; Sanja Pekovic; Ljubisav Rakic; Mirjana Stojiljkovic
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

Review 7.  The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema.

Authors:  Peter Nissen Bjerring; Martin Eefsen; Bent Adel Hansen; Fin Stolze Larsen
Journal:  Metab Brain Dis       Date:  2008-12-03       Impact factor: 3.584

8.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 9.  From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Authors:  George B Richerson; Detlev Boison; Carl L Faingold; Philippe Ryvlin
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.